Berries such as blueberries and strawberries are high in anthocyanidins, a type of flavonoid antioxidant, which has been shown in previous studies to improve cognition. Analyzed data collected in the Nurses’ Health Study found that women who consumed 2 or more servings of strawberries and blueberries each week experienced a …
Read More »Diabetes In Control
New York Plans a Ban on Big Sizes of Sugary Drinks
New York City plans to enact a far-reaching ban on the sale of large sodas and other sugary drinks at restaurants, movie theaters and street carts. The proposed ban would affect virtually the entire menu of popular sugary drinks found in delis, fast-food franchises and even sports arenas, from energy …
Read More »Plain Water over Sodas Lowers Risk of Developing Diabetes
The results, based on more than 80,000 women followed for more than a decade, suggest that adding water to the sugary beverages a person drinks throughout the day won’t make a difference, but replacing sweet drinks with water could help stave off the metabolic disorder. The amount of water women …
Read More »The EmPower Diabetes Emergency Plan
ACE and Lilly Diabetes have launched the “EmPower Diabetes Emergency Plan” with comprehensive tips to help people with diabetes prepare for emergencies such as natural disasters or even extended power outages. Every patient with diabetes needs to be prepared for the unexpected.
Read More »Accu-Chek-Glooko
Accu-Chek-Glooko Roche Diabetes Care and Glooko, Inc. join forces to provide ACCU-CHEK meter users an easy solution to download their meter readings directly into their Apple iPhone® or iPod touch. The new Glooko IR Adapter connects to the Glooko MeterSync Cable to download blood glucose readings from ACCU-CHEK meters …
Read More »Janssen Submits NDA for Canagliflozin
Janssen Submits NDA for Canagliflozin Janssen Research & Development, LLC has submitted a New Drug Application (NDA) to the FDA seeking approval for the use of canagliflozin, an investigational, oral, once-daily, selective sodium glucose co-transporter 2 (SGLT2) inhibitor, for the treatment of adult patients with type 2 diabetes.
Read More »AACE: New Team Approach Improves Diabetes Outcomes and Lowers Medication Costs
An integrated wellness team approach to diabetes care is helping patients lower their prescription costs and improve their condition….
Read More »AACE: Exercise Improves Vascular Reactivity for Pre-diabetic Patients
Pre-diabetic patients who engage in regular aerobic exercise improve their vascular reactivity to nearly normal levels, even if no weight loss is achieved….
Read More »AACE: Liraglutide Shows Positive Results in Head to Head Study
Patients more likely to reach A1c target at any given time during 26 weeks’ treatment with liraglutide compared with both sitagliptin and exenatide….
Read More »AACE: Reality Weight-Loss TV Meets Medical Skeptics over Exercise
Medical community resists super intensive exercise-based weight-loss programs that shed pounds and reduce the risk for diabetes and other cardiovascular risk factors….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.